Docetaxel and zoledronic acid combination administered in two different sequences in hormone refractory prostate cancer patients: Phase I clinical study – ZANTE
G. Facchini, M. Caraglia, A. Morabito, S.G. Bruni, G. Nasti, P. Maiolino, S. Striano, A. Budillon, A. Di Napoli, M. Marra, C. Pisano, S. Pignata, F. Perrone, R.V. IaffaioliVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/j.ejcsup.2008.06.048
File:
PDF, 38 KB
english, 2008